1. Home
  2. SNGX vs BON Comparison

SNGX vs BON Comparison

Compare SNGX & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • BON
  • Stock Information
  • Founded
  • SNGX 1987
  • BON 2006
  • Country
  • SNGX United States
  • BON China
  • Employees
  • SNGX N/A
  • BON N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • SNGX Health Care
  • BON Health Care
  • Exchange
  • SNGX Nasdaq
  • BON Nasdaq
  • Market Cap
  • SNGX 7.4M
  • BON 6.6M
  • IPO Year
  • SNGX 1987
  • BON 2021
  • Fundamental
  • Price
  • SNGX $2.39
  • BON $1.32
  • Analyst Decision
  • SNGX
  • BON
  • Analyst Count
  • SNGX 0
  • BON 0
  • Target Price
  • SNGX N/A
  • BON N/A
  • AVG Volume (30 Days)
  • SNGX 44.9K
  • BON 28.9K
  • Earning Date
  • SNGX 03-14-2025
  • BON 02-21-2025
  • Dividend Yield
  • SNGX N/A
  • BON N/A
  • EPS Growth
  • SNGX N/A
  • BON N/A
  • EPS
  • SNGX N/A
  • BON 0.17
  • Revenue
  • SNGX $364,183.00
  • BON $23,844,556.00
  • Revenue This Year
  • SNGX N/A
  • BON $223.38
  • Revenue Next Year
  • SNGX $76.64
  • BON $18.82
  • P/E Ratio
  • SNGX N/A
  • BON $7.55
  • Revenue Growth
  • SNGX N/A
  • BON N/A
  • 52 Week Low
  • SNGX $1.83
  • BON $1.11
  • 52 Week High
  • SNGX $14.88
  • BON $5.60
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 43.83
  • BON 44.79
  • Support Level
  • SNGX $2.25
  • BON $1.22
  • Resistance Level
  • SNGX $2.60
  • BON $1.36
  • Average True Range (ATR)
  • SNGX 0.15
  • BON 0.11
  • MACD
  • SNGX 0.03
  • BON 0.01
  • Stochastic Oscillator
  • SNGX 52.27
  • BON 55.84

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products.

Share on Social Networks: